Single-Dose Oritavancin Treatment of Acute Bacterial Skin and Skin Structure Infections: SOLO Trial Efficacy by Eron Severity and Management Setting
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2193-6382
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Single-Dose Oritavancin Treatment of Acute Bacterial Skin and Skin Structure Infections: SOLO Trial Efficacy by Eron Severity and Management Setting ; day:1 ; month:7 ; year:2016 ; pages:1-9
Infectious diseases and therapy ; (1.7.2016), 1-9
- Creator
-
Deck, Daniel H.
- Contributor
-
Jordan, Jennifer M.
Holland, Thomas L.
Fan, Weihong
Wikler, Matthew A.
Sulham, Katherine A.
Ralph Corey, G.
SpringerLink (Online service)
- DOI
-
10.1007/s40121-016-0119-9
- URN
-
urn:nbn:de:1111-2016070315701
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:50 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Deck, Daniel H.
- Jordan, Jennifer M.
- Holland, Thomas L.
- Fan, Weihong
- Wikler, Matthew A.
- Sulham, Katherine A.
- Ralph Corey, G.
- SpringerLink (Online service)
Other Objects (12)
Erratum to: Single-Dose Oritavancin Treatment of Acute Bacterial Skin and Skin Structure Infections: SOLO Trial Efficacy by Eron Severity and Management Setting
Delafloxacin: A Review in Acute Bacterial Skin and Skin Structure Infections
Correction to: Delafloxacin: A Review in Acute Bacterial Skin and Skin Structure Infections
Patient preferences for treatment of acute bacterial skin and skin structure infections in the emergency department
Financial Analysis of Dalbavancin for Acute Bacterial Skin and Skin Structure Infections for Self-Pay Patients
Bacterial cell-free metabolites-based zinc oxide nanoparticles for combating skin-causing bacterial infections
Oritavancin (KIMYRSA™) in acute bacterial skin and skin structure infections: a profile of its use in the USA
Bestatin in the treatment of chronic reoccurring bacterial infections of the skin
Peculiar evolution of streptococcal skin infections
Bacterial Skin Dysbiosis in Darier Disease
Dalbavancin Reduces Hospital Stay and Improves Productivity for Patients with Acute Bacterial Skin and Skin Structure Infections: The ENHANCE Trial
A Multicenter Evaluation of Vancomycin-Associated Acute Kidney Injury in Hospitalized Patients with Acute Bacterial Skin and Skin Structure Infections
Erratum to: Single-Dose Oritavancin Treatment of Acute Bacterial Skin and Skin Structure Infections: SOLO Trial Efficacy by Eron Severity and Management Setting
Delafloxacin: A Review in Acute Bacterial Skin and Skin Structure Infections
Correction to: Delafloxacin: A Review in Acute Bacterial Skin and Skin Structure Infections
Patient preferences for treatment of acute bacterial skin and skin structure infections in the emergency department
Financial Analysis of Dalbavancin for Acute Bacterial Skin and Skin Structure Infections for Self-Pay Patients
Bacterial cell-free metabolites-based zinc oxide nanoparticles for combating skin-causing bacterial infections
Oritavancin (KIMYRSA™) in acute bacterial skin and skin structure infections: a profile of its use in the USA
Bestatin in the treatment of chronic reoccurring bacterial infections of the skin
Peculiar evolution of streptococcal skin infections
Bacterial Skin Dysbiosis in Darier Disease
Dalbavancin Reduces Hospital Stay and Improves Productivity for Patients with Acute Bacterial Skin and Skin Structure Infections: The ENHANCE Trial
A Multicenter Evaluation of Vancomycin-Associated Acute Kidney Injury in Hospitalized Patients with Acute Bacterial Skin and Skin Structure Infections
Erratum to: Single-Dose Oritavancin Treatment of Acute Bacterial Skin and Skin Structure Infections: SOLO Trial Efficacy by Eron Severity and Management Setting
Delafloxacin: A Review in Acute Bacterial Skin and Skin Structure Infections
Correction to: Delafloxacin: A Review in Acute Bacterial Skin and Skin Structure Infections
Patient preferences for treatment of acute bacterial skin and skin structure infections in the emergency department
Financial Analysis of Dalbavancin for Acute Bacterial Skin and Skin Structure Infections for Self-Pay Patients
Bacterial cell-free metabolites-based zinc oxide nanoparticles for combating skin-causing bacterial infections
Oritavancin (KIMYRSA™) in acute bacterial skin and skin structure infections: a profile of its use in the USA
Bestatin in the treatment of chronic reoccurring bacterial infections of the skin
Peculiar evolution of streptococcal skin infections
Bacterial Skin Dysbiosis in Darier Disease
Dalbavancin Reduces Hospital Stay and Improves Productivity for Patients with Acute Bacterial Skin and Skin Structure Infections: The ENHANCE Trial